164 related articles for article (PubMed ID: 35240257)
21. Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study).
Lim S; Han KA; Yu J; Chamnan P; Kim ES; Yoon KH; Kwon S; Moon MK; Lee KW; Kim DJ; Kim M; Wongtanate M; Kim EY; Kim SH; Lee MK;
Diabetes Obes Metab; 2017 Jan; 19(1):87-97. PubMed ID: 27619558
[TBL] [Abstract][Full Text] [Related]
22. SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin.
Li Q; Liu F; Zheng TS; Tang JL; Lu HJ; Jia WP
Acta Pharmacol Sin; 2010 Feb; 31(2):184-90. PubMed ID: 20139901
[TBL] [Abstract][Full Text] [Related]
23. SLC47A1 gene rs2289669 G>A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients.
He R; Zhang D; Lu W; Zheng T; Wan L; Liu F; Jia W
Diabetes Res Clin Pract; 2015 Jul; 109(1):57-63. PubMed ID: 26004431
[TBL] [Abstract][Full Text] [Related]
24. Effects of the genetic variants of organic cation transporters 1 and 3 on the pharmacokinetics of metformin in Jordanians.
Hakooz N; Jarrar YB; Zihlif M; Imraish A; Hamed S; Arafat T
Drug Metab Pers Ther; 2017 Sep; 32(3):157-162. PubMed ID: 28862982
[TBL] [Abstract][Full Text] [Related]
25. Allele frequency and genotype distribution of a common variant in the 3´-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin.
Ghaffari-Cherati M; Mahrooz A; Hashemi-Soteh MB; Hosseyni-Talei SR; Alizadeh A; Nakhaei SM
J Res Med Sci; 2016; 21():92. PubMed ID: 28163738
[TBL] [Abstract][Full Text] [Related]
26. Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study.
Garber AJ; Bruce S; Fiedorek FT
Clin Ther; 2002 Sep; 24(9):1401-13. PubMed ID: 12380632
[TBL] [Abstract][Full Text] [Related]
27. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial.
Charbonnel B; Steinberg H; Eymard E; Xu L; Thakkar P; Prabhu V; Davies MJ; Engel SS
Diabetologia; 2013 Jul; 56(7):1503-11. PubMed ID: 23604551
[TBL] [Abstract][Full Text] [Related]
29. Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial.
Matthews DR; Paldánius PM; Proot P; Chiang Y; Stumvoll M; Del Prato S;
Lancet; 2019 Oct; 394(10208):1519-1529. PubMed ID: 31542292
[TBL] [Abstract][Full Text] [Related]
30. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
[TBL] [Abstract][Full Text] [Related]
31. Transporters, TBC1D4, and ARID5B Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes.
Gonzalez-Covarrubias V; Sánchez-Ibarra H; Lozano-Gonzalez K; Villicaña S; Texis T; Rodríguez-Dorantes M; Cortés-Ramírez S; Lavalle-Gonzalez F; Soberón X; Barrera-Saldaña H
Pharmacology; 2021; 106(11-12):588-596. PubMed ID: 34265779
[TBL] [Abstract][Full Text] [Related]
32. Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes.
Vohra M; Sharma AR; Mallya S; Prabhu NB; Jayaram P; Nagri SK; Umakanth S; Rai PS
J Endocrinol Invest; 2023 Jun; 46(6):1205-1218. PubMed ID: 36528847
[TBL] [Abstract][Full Text] [Related]
33. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.
Shikata E; Yamamoto R; Takane H; Shigemasa C; Ikeda T; Otsubo K; Ieiri I
J Hum Genet; 2007; 52(2):117-122. PubMed ID: 17111267
[TBL] [Abstract][Full Text] [Related]
34. Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2.
Dong M; Gong ZC; Dai XP; Lei GH; Lu HB; Fan L; Qu J; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):824-9. PubMed ID: 21933224
[TBL] [Abstract][Full Text] [Related]
35. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
[TBL] [Abstract][Full Text] [Related]
36. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
37. Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients.
Zaharenko L; Kalnina I; Geldnere K; Konrade I; Grinberga S; Židzik J; Javorský M; Lejnieks A; Nikitina-Zake L; Fridmanis D; Peculis R; Radovica-Spalvina I; Hartmane D; Pugovics O; Tkáč I; Klimčáková L; Pīrāgs V; Klovins J
Eur J Endocrinol; 2016 Dec; 175(6):531-540. PubMed ID: 27609360
[TBL] [Abstract][Full Text] [Related]
38. Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.
Yang W; Liu J; Shan Z; Tian H; Zhou Z; Ji Q; Weng J; Jia W; Lu J; Liu J; Xu Y; Yang Z; Chen W
Lancet Diabetes Endocrinol; 2014 Jan; 2(1):46-55. PubMed ID: 24622668
[TBL] [Abstract][Full Text] [Related]
39. Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver.
García-Calzón S; Perfilyev A; Männistö V; de Mello VD; Nilsson E; Pihlajamäki J; Ling C
Clin Epigenetics; 2017; 9():102. PubMed ID: 28947922
[TBL] [Abstract][Full Text] [Related]
40. Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes.
Sumitani S; Morita S; Deguchi R; Hirai K; Mukai K; Utsu Y; Miki S; Sato B; Nakamura H; Kasayama S; Koga M
Ann Clin Biochem; 2015 Jan; 52(Pt 1):76-81. PubMed ID: 24604630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
